A recent study has reported that Parkinson’s can be distinguished from multiple system atrophy using new technology known as protein misfolding cyclic amplification.
Browsing: Parkinson’s disease
Researchers have discovered subcellular signs of young-onset Parkinson’s disease that emerge before symptoms arise. Additionally, further testing has revealed a drug that may reverse these cellular abnormalities.
The bacteria Bacillus subtilis has been found to prevent α-synuclein build up in C. elegans, offering further support to the idea that the gut microbiome can influence brain activity.
Having previously been demonstrated to allow dopamine replenishment, results of a recent clinical trial suggest nilotinib could be a safe and well-tolerated treatment for individuals with Parkinson’s disease.
Abstracts presented at SfN Neuroscience 2019 provide insight into how gene therapy advancements could be used treat diseases such as Parkinson’s and Alzheimer’s in the future.
In a large data study, researchers discover that terazosin, a drug typically used to treat enlarged prostate, might be able to slow down neurodegeneration in Parkinson’s disease.
What have been the biggest headlines in industry this week? Take a look at our highlights including positive news about two monoclonal antibodies for relapsing multiple sclerosis and neuromyelitis optica spectrum disorder.
Researchers have identified that α-synuclein plays a role in DNA repair in neurons and that disruption of this function could lead to widespread death of neurons.
Ponesimod hits key endpoints in clinical trial for relapsing multiple sclerosis: industry news round-up
This week in industry includes trials on ponesimod for relapsing multiple sclerosis, the Accordion Pill® for Parkinson’s and cannabidiol oral solution for seizures.
A peek behind the paper – Sarah Hamm-Alvarez on oligomeric α-synuclein in basal tears of Parkinson’s patients
Take a look behind the scenes of a recent paper in Biomarkers in Medicine as we ask the author about oligomeric α-synuclein in basal tears of Parkinson’s patients.